A61K 51/1268
Host-guest, closed hollow molecules, inclusion complexes
Official title: {host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes}
A61K51/1268 (Host-guest, closed hollow molecules, inclusion complexes) appears on 49 US grants and 36 published applications in this corpus.
Search patents in A61K- Granted patents
- 49
- Published applications
- 36
- Assignees
- 29
- Inventors
- 111
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 5 |
| 2004 | 2 | 4 |
| 2005 | 3 | 6 |
| 2006 | 1 | 1 |
| 2007 | 1 | 3 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 0 | 5 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 3 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Radiopharmaceuticals including encapsulated GA+99mTc30 Dec 2025US 12,508,330 B1Kuwait University
- Self assembling molecules for targeted drug delivery6 Jun 2023US 11,666,664 B2The General Hospital Corporation
- Production of Lu-177 and other radionuclides via hot atom capture on nanostructured carbon6 Dec 2022US 11,517,633 B2Board of Regents, The University of Texas System
- Therapeutic and imaging compositions and uses thereof23 Jun 2020US 10,689,462 B2Purdue Research Foundation
- Therapeutic and imaging compositions and uses thereof19 Jun 2018US 10,000,581 B2Purdue Research Foundation
- Production of lu-177 and other radionuclides via hot atom capture on nanostructured carbon23 Jun 2022US 2022/0193276 A1Board of Regents, The University of Texas System
- Self assembling molecules for targeted drug delivery12 Mar 2020US 2020/0078472 A1The General Hospital Corporation
- Therapeutic and imaging compositions and uses thereof13 Sep 2018US 2018/0258192 A1Purdue Research Foundation
- Self assembling molecules for targeted drug delivery24 May 2018US 2018/0140719 A1The General Hospital Corporation
- Therapeutic and imaging compositions and uses thereof24 Mar 2016US 2016/0083485 A1Purdue Research Foundation
Most cited
By later US patents
- Pretargeting methods and compounds125US 6,217,869 B1NeoRx Corporation · 2001
- Self-assembling multimeric nucleic acid constructs98US 5,561,043 ATrustees of Boston University · 1996
- Use of fullerenes in diagnostic and/or therapeutic agents95US 5,688,486 ANycomed Salutar, Inc. · 1997
- Pretargeting methods and compounds47US 5,541,287 ANeoRx Corporation · 1996
- Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore47US 5,976,535 ANeoRx Corporation · 1999